YAREMA KRISTIN (President, Cell Therapy) received a stock award from POSEIDA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/4/2024ACC: 0000950170-24-001835
Officer· President, Cell Therapy
Since Apr 2023
+595.20K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
595.20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+250K
Price / share
—
Trade value
—
% of position
70.1%
1/2/2024
356.84K→606.84K
Total
Net shares
+250K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2024 | A · Award | +250K | — | — | 70.1% | 356.84K | 606.84K |
| Total | +250K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to buy)
Direct
Converts to
Common Stock
345.20K shares
Shares
+345.20K
Strike price
3.38
Held after
345.20K
Exercisable
—
1/2/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) Direct | Common Stock345.20K shares | 1/2/2024 | A · Award | +345.20K | 3.38 | — | 345.20K |